Press release
Immuno-Oncology Market to Reach USD 196.4 Billion by 2030,registering a strong CAGR of 11.5%
Immuno-Oncology Market
Introduction
The Immuno-Oncology (IO) Market continues to dominate global cancer therapeutics, transforming patient outcomes through precision-driven, immune-based treatments. IO therapies-including immune checkpoint inhibitors (ICI), CAR-T cell therapy, bispecific antibodies, cancer vaccines, TIL therapies, and oncolytic viruses-have redefined survival expectations across solid tumors and hematologic malignancies.
Major pharmaceutical companies are accelerating R&D in ICI combinations, personalized tumor vaccines, NK-cell therapy, and AI-optimized biomarker discovery. Expanding indications, growing regulatory approvals, and increased adoption in emerging markets are driving powerful market momentum.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/73661
Key Takeaways
• Market Size (2023): USD 92.3 Billion
• Market Size (2030): USD 196.4 Billion
• CAGR (2024-2030): 11.5%
• Checkpoint inhibitors represent over 42% of total revenue.
• Major players include Merck (Keytruda), Bristol-Myers Squibb (Opdivo, Yervoy), Novartis, Roche, AstraZeneca, GSK, Pfizer, Johnson & Johnson, Gilead/Kite Pharma, Amgen, and Moderna.
• Emerging technologies include neoantigen vaccines, NK-cell therapy, bispecific T-cell engagers (BiTEs), and AI-driven IO diagnostics.
Market Story
Immuno-oncology is expanding into a multi-platform therapeutic domain powered by:
1. Checkpoint Inhibitors Lead Global Market Growth
Keytruda, Opdivo, Tecentriq, Imfinzi, and Libtayo continue to dominate IO revenue due to:
• Multi-tumor approvals
• Expanded adjuvant/neoadjuvant indications
• Combination therapy dominance
• Strong real-world survival improvements
Checkpoint inhibitors remain the backbone of modern cancer therapy.
2. CAR-T Cell Therapy Expands Beyond Hematology
CAR-T therapies generated USD 7.1 billion in 2023 and are expected to grow rapidly as:
• Next-gen CAR-T enters solid tumors
• Allogeneic "off-the-shelf" CAR-T trials progress
• Manufacturing timelines shorten
• Safety profiles improve through gene-editing tools
Major players include Kite Pharma, Novartis, BMS, JW Therapeutics, and Legend Biotech.
3. Personalized Cancer Vaccines & Neoantigen Platforms Surge
mRNA and DNA-based cancer vaccines are advancing due to successes demonstrated by:
• Moderna + Merck's mRNA-4157 (Phase II melanoma success)
• Multi-omic neoantigen targeting platforms
• AI-designed antigen selection
This category is expected to grow at >15% CAGR through 2030.
4. Tumor Microenvironment (TME) Modulators Show Strong Promise
New mechanisms include:
• Myeloid-targeted therapies
• Treg modulators
• Oncolytic viruses
• STING & TLR agonists
These expand IO's reach to previously resistant tumor types.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/73661/immuno-oncology-market
Market Segments
By Therapy Type
• Immune Checkpoint Inhibitors (PD-1, PD-L1, CTLA-4)
• CAR-T Cell Therapies (Autologous & Allogeneic)
• Cancer Vaccines (mRNA, DNA, Peptide, Neoantigen)
• Oncolytic Viral Therapies
• Tumor-Infiltrating Lymphocyte (TIL) Therapies
• NK-Cell & Macrophage-Based Therapies
• Bispecific Antibodies (BiTEs)
• Adoptive Cell Therapy (ACT)
By Cancer Type
• Lung Cancer (largest segment)
• Melanoma
• Breast Cancer
• Colorectal Cancer
• Bladder & Renal Cancers
• Hematologic Malignancies (ALL, DLBCL, MM)
• Prostate Cancer
• Head & Neck Cancer
• Ovarian & Cervical Cancer
By Biomarker Type
• PD-L1 Expression
• Tumor Mutational Burden (TMB)
• MSI-High/dMMR
• Gene Expression Signatures
• Neoantigen Profiling
• Circulating Tumor DNA (ctDNA)
By End User
• Hospitals & Oncology Centers
• Immunotherapy Clinics
• Academic Institutes
• Specialized CAR-T Treatment Centers
By Region
• North America - largest, fastest in approvals
• Europe - strong in TIL/TME trials
• Asia-Pacific - highest CAGR due to China's IO boom
• Latin America & Middle East - improving access
Recent Developments
• Merck expanded Keytruda across new adjuvant settings globally.
• BMS reported strong Opdivo+Yervoy combination results in melanoma & lung cancer.
• AstraZeneca advanced Imfinzi into multiple solid-tumor lines.
• Novartis progressed T-cell-based immunotherapies and next-gen CAR-T platforms.
• Gilead/Kite expanded global CAR-T manufacturing capacity.
• Moderna advanced its personalized mRNA cancer vaccine into Phase III.
• Amgen accelerated BiTE expansion into solid tumors.
Get Your Exclusive Offer with up to 10% Discount
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=73661
Expert Quote
"Immuno-oncology continues to be the most disruptive force in cancer care. AI-designed therapies, personalized vaccines, and next-generation cellular therapies are expanding survival benefits across tumor types."
-Irfan Tamboli, Business Development Executive, Exactitude Consultancy
Market Drivers
• Growing cancer incidence worldwide
• Expansion of checkpoint inhibitors & combination therapies
• Advances in mRNA and neoantigen vaccine technologies
• Increasing approvals of CAR-T and TIL therapies
• Favorable regulatory pathways (FDA breakthrough designations)
• AI-powered biomarker discovery accelerating personalized treatment
• Strong pharma mergers & acquisitions boosting IO pipeline value
Forecast Outlook
The IO Market will surpass USD 196.4 billion by 2030 driven by:
• Strong global adoption of checkpoint inhibitors
• Commercialization of allogeneic CAR-T therapies
• Breakthrough success of personalized cancer vaccines
• Regulatory approvals across Asia-Pacific and LATAM
• AI-linked clinical decision tools improving treatment response rates
Regional Highlights
• U.S.: Leading due to large IO infrastructure and reimbursement support
• Europe: Growing with advanced CAR-T and cell therapy centers
• China & Japan: Fastest expansion in checkpoint inhibitor uptake
• Middle East: Increasing investment in oncology centers
Government & Regulatory Initiatives
• FDA priority review for IO-combination therapies
• EMA accelerated pathways for CAR-T & mRNA oncology platforms
• China NMPA supports rapid approvals for PD-1 inhibitors
• National cancer immunotherapy funding programs
• Multi-country precision oncology initiatives integrating AI and genomics
Conclusion
The Immuno-Oncology Market is entering a new era centered around personalized vaccines, multi-mechanism biologics, cellular therapies, and AI-enhanced precision medicine. Companies investing in integrated IO ecosystems will dominate global oncology innovation through 2030.
This report is also available in the following languages : Japanese (免疫腫瘍学市場), Korean (면역 종양학 시장), Chinese (免疫肿瘤学市场), French (Marché de l'immuno-oncologie), German (Markt für Immunonkologie), and Italian (Mercato dell'immuno-oncologia), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/73661
Our More Reports:
Cryopreservation Bags and Freezing Bags Market
https://exactitudeconsultancy.com/reports/73513/cryopreservation-bags-and-freezing-bags-market
Buffer Preparation Market
https://exactitudeconsultancy.com/reports/73515/buffer-preparation-market
Fermenters and Bioreactors Market
https://exactitudeconsultancy.com/reports/73517/fermenters-and-bioreactors-market
Plaque Psoriasis in 68 Market
https://exactitudeconsultancy.com/reports/73643/plaque-psoriasis-in-68-market
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Immuno-Oncology Market to Reach USD 196.4 Billion by 2030,registering a strong CAGR of 11.5% here
News-ID: 4295348 • Views: …
More Releases from Exactitude Consultancy
Cold Planer Market Sees Consistent Growth Supported by Global Road Rehabilitatio …
The global cold planer market is experiencing steady growth as governments and private contractors increase spending on road rehabilitation, resurfacing, and infrastructure modernization. Cold planers, also known as milling machines, are widely used to remove damaged asphalt and concrete surfaces efficiently, supporting sustainable road construction practices.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68250
Key Market Highlights
• Increasing focus on road maintenance and resurfacing projects
• Growing demand for efficient and precision milling…
Credit Management Software Market Accelerates as Organizations Focus on Risk Mit …
The global credit management software market is witnessing robust growth as organizations across industries adopt digital solutions to manage credit risk, improve receivables performance, and strengthen financial controls. Credit management software enables businesses to automate credit scoring, monitor customer creditworthiness, and streamline collections processes.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68248
Key Market Highlights
• Growing adoption of automated credit risk assessment tools
• Increasing focus on working capital and cash flow management
• Integration…
Session Border Controller Market Expands Rapidly as Enterprises and Telecom Oper …
The global session border controller (SBC) market is experiencing strong growth as telecom operators and enterprises increasingly deploy SBC solutions to secure, manage, and optimize real-time IP communications. SBCs play a critical role in protecting voice over IP (VoIP), unified communications (UC), and multimedia sessions from cyber threats while ensuring interoperability and quality of service.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68246
Key Market Highlights
• Growing adoption of VoIP and…
Biofuel Market Including E-Methane and Sustainable Aviation Fuel Gains Strong Tr …
The global biofuel market, encompassing e-methane, sustainable aviation fuel (SAF), and other advanced biofuels, is witnessing robust growth as governments and industries intensify efforts to reduce carbon emissions and transition toward cleaner energy sources. These fuels play a critical role in achieving net-zero targets while enabling decarbonization of hard-to-abate sectors such as aviation, shipping, and heavy transportation.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68244
Key Market Highlights
• Rapid growth of…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
